ArticleCureus2026
Multiple Clinical Applications of a Dialkylcarbamoyl Chloride (DACC)-Coated Dressing in the Management of an Extensive Skin Defect: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dialkylcarbamoyl chloride (DACC)-coated dressings physically bind and remove microorganisms through hydrophobic interactions and are widely used for various types of wounds, ranging from acute to chronic. However, few reports have comprehensively described their practical applications across different stages of wound management. We report the case of an 86-year-old woman with extensive skin necrosis of the lower extremity in whom DACC-coated dressings were used for four distinct purposes: as a standalone dressing, as a contact layer during negative pressure wound therapy (NPWT), as a contact layer for a skin graft, and as an interface with cadexomer iodine ointment. After debridement, a Sorbact
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.